Spironolactone in end stage renal disease: A story of under'ACHIEVE'ment. [PDF]
J Bras NefrolMathew GG.
europepmc +1 more source
Prevention is less expensive than treatment in chronic kidney disease: a descriptive analysis. [PDF]
J Bras NefrolAlcalde PR, Fernandes DE, Kirsztajn GM.
europepmc +1 more source
Endothelial Function by Flow-Mediated Dilation (FMD) in the Brachial Artery in Hypertensive Patients. [PDF]
Arq Bras CardiolTessier EAS +7 more
europepmc +1 more source
Subclinical Atrial Fibrillation Screening in Dialytic Chronic Kidney Disease Patients Using Portable Device. [PDF]
Arq Bras CardiolCarvalho APV +6 more
europepmc +1 more source
High prevalence of hyperkalemia in Brazilian chronic dialysis patients and differences across geographic regions. [PDF]
J Bras Nefrol, 2023 Nerbass FB, Lima HN, Sesso R, Lugon JR.
europepmc +1 more source
Hyponatremia and the risk of Osmotic Demyelination Syndrome: is it time to review sodium correction rates? [PDF]
J Bras NefrolGomes CP.
europepmc +1 more source
Antihypertensive Effect of New Agonist of Adenosine Receptor in Spontaneously Hypertensive Rats. [PDF]
Arq Bras Cardiolde Souza Rocha B +5 more
europepmc +1 more source
Cardiac Magnetic Resonance Imaging in a 7 Tesla Magnetic Field: Initial Experience with Hydrogen and Sodium Nuclei. [PDF]
Arq Bras Cardiol, 2023 Rochitte CE +5 more
europepmc +1 more source
Prevalence of anemia in patients with chronic kidney disease attended at a nephrology outpatient clinic and its association with the outcome of renal replacement therapy over five years: a retrospective cohort study, Municipality of São Paulo, 2010-2018. [PDF]
Epidemiol Serv SaudeMiyahara AK +9 more
europepmc +1 more source
The Adenosine System as a Target in the Search for a New Class of Antihypertensives. [PDF]
Arq Bras CardiolFranco RJDS.
europepmc +1 more source